Harnessing natural killer cell effector function against cancer. (2024)
Attributed to:
Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/immadv/ltad031
PubMed Identifier: 38223411
Publication URI: http://europepmc.org/abstract/MED/38223411
Type: Journal Article/Review
Volume: 4
Parent Publication: Immunotherapy advances
Issue: 1
ISSN: 2732-4303